Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Georgina Torrandell‐Haro"'
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
ObjectiveAs neuropsychiatric conditions can increase the risk of age-related neurodegenerative diseases (NDDs), the impact of CNS-active drugs on the risk of developing Alzheimer’s Disease (AD), non-AD dementia, Multiple Sclerosis (MS), Parkinson
Externí odkaz:
https://doaj.org/article/bdd748d6dcf4460794c10a256e6ae1e3
Autor:
Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, Edward P. Gelmann, Francesca Vitali, Kathleen E. Rodgers, Roberta Diaz Brinton
Publikováno v:
Cancer Medicine, Vol 11, Iss 13, Pp 2687-2698 (2022)
Abstract Background Prostate cancer and multiple neurodegenerative diseases (NDD) share an age‐associated pattern of onset. Therapy of prostate cancer is known to impact cognitive function. The objective of this study was to determine the impact of
Externí odkaz:
https://doaj.org/article/2f86eed833b0440e94f34ba97605113c
Autor:
Gregory L. Branigan, Georgina Torrandell-Haro, Francesca Vitali, Roberta Diaz Brinton, Kathleen Rodgers
Publikováno v:
Heliyon, Vol 8, Iss 10, Pp e11196- (2022)
Background: The association between exposure to anti-hyperglycemic medications (A-HgM) for Type 2 Diabetes Mellitus (T2D) treatment and Multiple Sclerosis (MS) in T2D patients is unclear. Methods: This retrospective cohort analysis used the Mariner c
Externí odkaz:
https://doaj.org/article/2d1af1a0f0c74cfeaaddc4e00b69c494
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
ObjectiveWe sought to determine the impact of Type 2 Diabetes Mellitus (T2D) anti-hyperglycemic medications (A-HgM) on risk of Alzheimer’s disease (AD) and related dementias (ADRD) outcomes including vascular dementia, and non-AD dementia such as f
Externí odkaz:
https://doaj.org/article/84f9adefd7074cf7b0e02ca4e222bd19
Autor:
Georgina Torrandell‐Haro, Gregory L. Branigan, Francesca Vitali, Nophar Geifman, Julie M. Zissimopoulos, Roberta Diaz Brinton
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Establishing efficacy of and molecular pathways for statins has the potential to impact incidence of Alzheimer's and age‐related neurodegenerative diseases (NDD). Methods This retrospective cohort study surveyed US‐based Hum
Externí odkaz:
https://doaj.org/article/3969c8e9f66d49f7bf80280f9918f479
Autor:
Roberta Diaz Brinton, Francesca Vitali, Georgina Torrandell-Haro, Gregory Branigan, Juan Arias Aristizabal, Eric Reiman, Edward J Bedrick, Craig Weinkauf
Publikováno v:
Stroke and Vascular Neurology, Vol , Iss
Background In the absence of a cerebrovascular accident, whether asymptomatic extracranial carotid atherosclerotic disease (aECAD) affects Alzheimer’s disease (AD) and non-AD dementia risk is not clear. Understanding whether aECAD is associated wit
Externí odkaz:
https://doaj.org/article/2da54978080541539107d8d98f3cbdb4
Autor:
Gregory Branigan, Georgina Torrandell Haro, Francesca Vitali, Roberta Brinton, Kathleen Rodgers
Publikováno v:
Tuesday, April 25.
Autor:
Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, Edward P. Gelmann, Francesca Vitali, Kathleen E. Rodgers, Roberta Diaz Brinton
Publikováno v:
Cancer Medicine. 11:2687-2698
Prostate cancer and multiple neurodegenerative diseases (NDD) share an age-associated pattern of onset. Therapy of prostate cancer is known to impact cognitive function. The objective of this study was to determine the impact of multiple classes of a
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Alzheimer's & Dementia. 17